Elective Coronary Revascularization Procedures in Patients With Stable Coronary Artery Disease: Incidence,

Martial Hamon1, Gilles Lemesle2, Thibaud Meurice3

  • 1University Hospital of Caen, Caen University, Caen, France.

Insights

Elective coronary revascularization (ECR) occurs annually in 1.8% of stable coronary artery disease (CAD) patients on secondary prevention. ECR did not impact the risk of death, myocardial infarction, or ischemic stroke in this cohort.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • Limited observational data exist on elective coronary revascularization (ECR) in stable coronary artery disease (CAD) patients receiving modern secondary prevention.
  • Understanding ECR trends and outcomes in this population is crucial for clinical practice guidelines.

Purpose of the Study:

  • To describe the incidence, determinants, and outcomes of ECR in patients with stable CAD.
  • To evaluate the association between ECR and subsequent adverse cardiovascular events.

Main Methods:

  • Analysis of a prospective, multicenter registry (CORONOR) of 4,094 stable CAD outpatients with 5-year follow-up.
  • Assessment of secondary prevention medication use at baseline.
  • Identification of factors associated with ECR and its impact on mortality, myocardial infarction, and ischemic stroke.

Main Results:

  • The 5-year cumulative incidence of ECR was 8.9% (1.8% per year).
  • Seven variables independently predicted ECR: prior stent, no prior MI, higher LDL-C, younger age, multivessel CAD, diabetes, and no RAS antagonist use.
  • Indications for ECR included angina with positive stress test (31%), silent ischemia (31%), and angina alone (25%).

Conclusions:

  • ECR is performed in 1.8% annually among stable CAD patients on comprehensive secondary medical prevention.
  • ECR procedures are performed even without noninvasive stress tests.
  • Elective coronary revascularization was not associated with a reduced risk of subsequent ischemic adverse events.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
516
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
298
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
411
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
733
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.5K